EP1203343A1 - Detection automatique d'objets dans un echantillon biologique - Google Patents
Detection automatique d'objets dans un echantillon biologiqueInfo
- Publication number
- EP1203343A1 EP1203343A1 EP00947299A EP00947299A EP1203343A1 EP 1203343 A1 EP1203343 A1 EP 1203343A1 EP 00947299 A EP00947299 A EP 00947299A EP 00947299 A EP00947299 A EP 00947299A EP 1203343 A1 EP1203343 A1 EP 1203343A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- interest
- slide
- image
- candidate object
- stage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 18
- 239000012472 biological sample Substances 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 143
- 230000002062 proliferating effect Effects 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 238000012545 processing Methods 0.000 claims description 38
- 206010028980 Neoplasm Diseases 0.000 claims description 26
- 101150029707 ERBB2 gene Proteins 0.000 claims description 21
- 230000003287 optical effect Effects 0.000 claims description 17
- 239000013642 negative control Substances 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 14
- 239000013641 positive control Substances 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 12
- 102000005962 receptors Human genes 0.000 claims description 7
- 108020003175 receptors Proteins 0.000 claims description 7
- 208000026310 Breast neoplasm Diseases 0.000 claims description 5
- 238000004590 computer program Methods 0.000 claims description 4
- 206010006187 Breast cancer Diseases 0.000 claims description 3
- 229940046836 anti-estrogen Drugs 0.000 claims description 3
- 230000001833 anti-estrogenic effect Effects 0.000 claims description 3
- 239000000328 estrogen antagonist Substances 0.000 claims description 3
- 239000003418 antiprogestin Substances 0.000 claims description 2
- 230000003623 progesteronic effect Effects 0.000 claims description 2
- 208000035269 cancer or benign tumor Diseases 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000011002 quantification Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 109
- 238000004458 analytical method Methods 0.000 description 56
- 230000008569 process Effects 0.000 description 54
- 238000003364 immunohistochemistry Methods 0.000 description 35
- 210000001519 tissue Anatomy 0.000 description 27
- 238000010186 staining Methods 0.000 description 26
- 230000006870 function Effects 0.000 description 23
- 238000010586 diagram Methods 0.000 description 21
- 238000012552 review Methods 0.000 description 20
- 210000004881 tumor cell Anatomy 0.000 description 19
- 230000000877 morphologic effect Effects 0.000 description 17
- 239000000523 sample Substances 0.000 description 17
- 239000011159 matrix material Substances 0.000 description 15
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 14
- 239000000969 carrier Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 238000011068 loading method Methods 0.000 description 11
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 10
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 238000005286 illumination Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 238000010191 image analysis Methods 0.000 description 9
- 102000015694 estrogen receptors Human genes 0.000 description 8
- 108010038795 estrogen receptors Proteins 0.000 description 8
- 210000004940 nucleus Anatomy 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 7
- 241000725303 Human immunodeficiency virus Species 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 230000002055 immunohistochemical effect Effects 0.000 description 6
- 102000003998 progesterone receptors Human genes 0.000 description 6
- 108090000468 progesterone receptors Proteins 0.000 description 6
- 208000003788 Neoplasm Micrometastasis Diseases 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 210000000805 cytoplasm Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000002018 overexpression Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000008399 tap water Substances 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 4
- 230000010339 dilation Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 210000004088 microvessel Anatomy 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108700020796 Oncogene Proteins 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000013060 biological fluid Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- MPBRYMWMMKKRGC-UHFFFAOYSA-M carbocyanin DBTC Chemical compound [Br-].C1=CC=CC2=C([N+](=C(C=C(C)C=C3N(C4=C5C=CC=CC5=CC=C4S3)CC)S3)CC)C3=CC=C21 MPBRYMWMMKKRGC-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000006059 cover glass Substances 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000012309 immunohistochemistry technique Methods 0.000 description 3
- 238000012744 immunostaining Methods 0.000 description 3
- 230000036210 malignancy Effects 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 101000945496 Homo sapiens Proliferation marker protein Ki-67 Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000013394 immunophenotyping Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000011344 liquid material Substances 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 230000001394 metastastic effect Effects 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 210000001995 reticulocyte Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241001092081 Carpenteria Species 0.000 description 1
- 206010008263 Cervical dysplasia Diseases 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 206010063045 Effusion Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 108010020437 Ki-67 Antigen Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000007660 Residual Neoplasm Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000001164 aluminium sulphate Substances 0.000 description 1
- 235000011128 aluminium sulphate Nutrition 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000004164 analytical calibration Methods 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000023549 cell-cell signaling Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000004883 computer application Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- BUACSMWVFUNQET-UHFFFAOYSA-H dialuminum;trisulfate;hydrate Chemical compound O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O BUACSMWVFUNQET-UHFFFAOYSA-H 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 238000012308 immunohistochemistry method Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008802 morphological function Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- IPSIPYMEZZPCPY-UHFFFAOYSA-N new fuchsin Chemical compound [Cl-].C1=CC(=[NH2+])C(C)=CC1=C(C=1C=C(C)C(N)=CC=1)C1=CC=C(N)C(C)=C1 IPSIPYMEZZPCPY-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000003793 prenatal diagnosis Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000015281 sodium iodate Nutrition 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- 229940032753 sodium iodate Drugs 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 102000005969 steroid hormone receptors Human genes 0.000 description 1
- 108020003113 steroid hormone receptors Proteins 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N1/31—Apparatus therefor
- G01N1/312—Apparatus therefor for samples mounted on planar substrates
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/60—Type of objects
- G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
Definitions
- the HER2/neu method uses an anti-HER2/neu
- HIV HIV p24 antigen levels
- H/E image is
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Multimedia (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Theoretical Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Image Input (AREA)
- Image Processing (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Microscoopes, Condenser (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14382399P | 1999-07-13 | 1999-07-13 | |
US143823P | 1999-07-13 | ||
PCT/US2000/019046 WO2001004828A1 (fr) | 1999-07-13 | 2000-07-12 | Detection automatique d'objets dans un echantillon biologique |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1203343A1 true EP1203343A1 (fr) | 2002-05-08 |
EP1203343A4 EP1203343A4 (fr) | 2006-08-23 |
Family
ID=22505818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00947299A Withdrawn EP1203343A4 (fr) | 1999-07-13 | 2000-07-12 | Detection automatique d'objets dans un echantillon biologique |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1203343A4 (fr) |
JP (1) | JP2003504627A (fr) |
AU (1) | AU6093400A (fr) |
WO (1) | WO2001004828A1 (fr) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1434522B1 (fr) | 2000-10-30 | 2010-01-13 | The General Hospital Corporation | Systemes optiques d'analyse de tissus |
US9897538B2 (en) | 2001-04-30 | 2018-02-20 | The General Hospital Corporation | Method and apparatus for improving image clarity and sensitivity in optical coherence tomography using dynamic feedback to control focal properties and coherence gating |
KR100458148B1 (ko) | 2001-10-29 | 2004-11-26 | 포라 가세이 고교 가부시키가이샤 | 피부 분석 시스템 |
US20030165263A1 (en) | 2002-02-19 | 2003-09-04 | Hamer Michael J. | Histological assessment |
GB0218909D0 (en) * | 2002-08-15 | 2002-09-25 | Qinetiq Ltd | Histological assessment |
US20060210129A1 (en) * | 2002-07-30 | 2006-09-21 | Deutsches Krebsforschungzentrum | Method and apparatus for multiple labeling detection and evaluation of a plurality of particles |
US7298885B2 (en) * | 2002-11-27 | 2007-11-20 | 3M Innovative Properties Company | Biological growth plate scanner with automated image processing profile selection |
US7648678B2 (en) * | 2002-12-20 | 2010-01-19 | Dako Denmark A/S | Method and system for pretreatment of tissue slides |
GB0305033D0 (en) * | 2003-03-05 | 2003-04-09 | Fairfield Imaging Ltd | Method for providing quantitative images for use in pathology analysis |
JP4805142B2 (ja) | 2003-03-31 | 2011-11-02 | ザ ジェネラル ホスピタル コーポレイション | 光路長が変更された異なる角度の光の合成により光学的に干渉する断層撮影におけるスペックルの減少 |
EP2290337B1 (fr) | 2003-06-06 | 2018-12-12 | The General Hospital Corporation | Laser à balayage de longueur d'onde |
DE102004009934A1 (de) * | 2004-02-26 | 2005-09-22 | Niendorf, Axel, Prof.Dr.med. | Verfahren zur Untersuchung einer Gewebeprobe |
WO2006014392A1 (fr) | 2004-07-02 | 2006-02-09 | The General Hospital Corporation | Sonde d'imagerie endoscopique comprenant des fibres double gaine |
ES2379468T3 (es) | 2004-08-24 | 2012-04-26 | The General Hospital Corporation | Procedimiento, sistema y configuración de software para determinar el módulo de elasticidad |
EP2275024A3 (fr) | 2004-08-24 | 2011-05-04 | The General Hospital Corporation | Procédé et appareil pour l'imagerie de segments de vaisseaux |
WO2006058346A1 (fr) | 2004-11-29 | 2006-06-01 | The General Hospital Corporation | Ensembles, dispositifs, endoscopes, catheters et methodes d'imagerie optique permettant d'eclairer et de detecter simultanement plusieurs points sur un echantillon |
US20060159367A1 (en) * | 2005-01-18 | 2006-07-20 | Trestle Corporation | System and method for creating variable quality images of a slide |
ATE451669T1 (de) * | 2005-04-28 | 2009-12-15 | Gen Hospital Corp | Bewertung von bildmerkmalen einer anatomischen struktur in optischen kohärenztomographiebildern |
EP1889037A2 (fr) | 2005-06-01 | 2008-02-20 | The General Hospital Corporation | Appareil, methode et systeme pour effectuer une imagerie de domaine de frequence optique a resolution de phase |
EP1912060A1 (fr) * | 2005-07-29 | 2008-04-16 | Olympus Corporation | Procédé de mesure d intensité de lumière et dispositif de mesure d intensité de lumière |
ATE484727T1 (de) | 2005-08-09 | 2010-10-15 | Gen Hospital Corp | Gerät und verfahren zur durchführung von polarisationsbasierter quadraturdemodulation bei optischer kohärenztomographie |
US20070121196A1 (en) | 2005-09-29 | 2007-05-31 | The General Hospital Corporation | Method and apparatus for method for viewing and analyzing of one or more biological samples with progressively increasing resolutions |
JP4808492B2 (ja) * | 2005-12-28 | 2011-11-02 | シスメックス株式会社 | 標本画像撮像装置、標本画像撮像システムおよび標本スライド供給装置 |
US8145018B2 (en) | 2006-01-19 | 2012-03-27 | The General Hospital Corporation | Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements |
JP5384944B2 (ja) | 2006-01-19 | 2014-01-08 | ザ ジェネラル ホスピタル コーポレイション | ビームスキャニングによる上皮性管腔器官の光学的撮像システム |
WO2007149602A2 (fr) | 2006-02-01 | 2007-12-27 | The General Hospital Corporation | Procédés et systèmes d'application d'un rayonnement électromagnétique sur au moins une partie d'un échantillon au moyen de procédures thérapeutiques laser conformationnelles |
WO2007149603A2 (fr) | 2006-02-01 | 2007-12-27 | The General Hospital Corporation | Appareil destiné à appliquer une pluralité de rayonnements électromagnétiques à un échantillon |
EP2306141A1 (fr) | 2006-02-24 | 2011-04-06 | The General Hospital Corporation | Procédés et systèmes destinés à réaliser une tomographie par cohérence optique dans le domaine de Fourier avec résolution angulaire |
EP2015669A2 (fr) | 2006-05-10 | 2009-01-21 | The General Hospital Corporation | Processus, agencements et systèmes pour obtenir une imagerie de domaine de fréquence d'un échantillon |
EP2042853B1 (fr) * | 2006-07-12 | 2014-04-23 | Toyobo Co., Ltd. | Analyseur et son utilisation |
US8838213B2 (en) | 2006-10-19 | 2014-09-16 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
JP5063999B2 (ja) * | 2006-11-30 | 2012-10-31 | シスメックス株式会社 | 血液像分析装置 |
JP4938428B2 (ja) * | 2006-12-01 | 2012-05-23 | シスメックス株式会社 | 標本画像作成方法及び装置 |
WO2008108059A1 (fr) * | 2007-03-01 | 2008-09-12 | Nec Corporation | Système, procédé et programme pour le diagnostic d'images pathologiques de cancer mammaire, et support d'enregistrement du programme |
WO2008118781A2 (fr) | 2007-03-23 | 2008-10-02 | The General Hospital Corporation | Procédés, agencements et dispositif destinés à utiliser un laser à balayage de longueur d'onde utilisant un balayage angulaire et des procédures de dispersion |
US10534129B2 (en) | 2007-03-30 | 2020-01-14 | The General Hospital Corporation | System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque |
US9375158B2 (en) | 2007-07-31 | 2016-06-28 | The General Hospital Corporation | Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging |
CH708797B1 (de) * | 2007-08-17 | 2015-05-15 | Tecan Trading Ag | Probenteil-Magazin für eine Objektträger-Transportvorrichtung eines Laser Scanner-Geräts. |
WO2009111298A2 (fr) | 2008-03-04 | 2009-09-11 | 3M Innovative Properties Company | Traitement de milieux de croissance biologiques basé sur des caractéristiques de fabrication mesurées |
WO2009125547A1 (fr) * | 2008-04-09 | 2009-10-15 | 株式会社ニコン | Régulateur d'appareil de culture et programme de régulation |
US9254089B2 (en) | 2008-07-14 | 2016-02-09 | The General Hospital Corporation | Apparatus and methods for facilitating at least partial overlap of dispersed ration on at least one sample |
EP3330696B1 (fr) | 2008-12-10 | 2023-07-12 | The General Hospital Corporation | Systèmes, appareil et procédés d'extension de la plage de profondeur d'imagerie de tomographie par cohérence optique, par le biais du sous-échantillonnage optique |
US9615748B2 (en) | 2009-01-20 | 2017-04-11 | The General Hospital Corporation | Endoscopic biopsy apparatus, system and method |
EP2394336B1 (fr) | 2009-02-04 | 2023-05-24 | The General Hospital Corporation | Appareil et procédé d'utilisation d'une source d'ajustement de longueur d'onde optique à grande vitesse |
JP5316161B2 (ja) * | 2009-03-27 | 2013-10-16 | ソニー株式会社 | 観察装置 |
BR112012001042A2 (pt) | 2009-07-14 | 2016-11-22 | Gen Hospital Corp | equipamento e método de medição do fluxo de fluído dentro de estrutura anatômica. |
DK2542145T3 (da) | 2010-03-05 | 2020-11-02 | Massachusetts Gen Hospital | Systemer der tilvejebringer mikroskopiske billeder af mindst en anatomisk struktur ved en bestemt opløsning |
US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
WO2011149972A2 (fr) | 2010-05-25 | 2011-12-01 | The General Hospital Corporation | Systèmes, dispositifs, procédés, appareil et supports accessibles par ordinateur pour fournir une imagerie optique de structures et de compositions |
WO2011150069A2 (fr) | 2010-05-25 | 2011-12-01 | The General Hospital Corporation | Appareil, systèmes, procédés et support accessible par ordinateur pour l'analyse spectrale d'images de tomographie par cohérence optique |
EP2575591A4 (fr) | 2010-06-03 | 2017-09-13 | The General Hospital Corporation | Appareil et procédé pour dispositifs de structures d'imagerie, dans ou sur un ou plusieurs organes luminaux |
EP2601513B1 (fr) * | 2010-08-05 | 2014-05-14 | Cambridge Research & Instrumentation, Inc. | Amélioration de l'évaluation visuelle d'échantillons |
US9510758B2 (en) | 2010-10-27 | 2016-12-06 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
JP2014523536A (ja) | 2011-07-19 | 2014-09-11 | ザ ジェネラル ホスピタル コーポレイション | 光コヒーレンストモグラフィーにおいて偏波モード分散補償を提供するためのシステム、方法、装置およびコンピュータアクセス可能な媒体 |
JP2015502562A (ja) | 2011-10-18 | 2015-01-22 | ザ ジェネラル ホスピタル コーポレイション | 再循環光学遅延を生成および/または提供するための装置および方法 |
EP2833776A4 (fr) | 2012-03-30 | 2015-12-09 | Gen Hospital Corp | Système d'imagerie, procédé et fixation distale permettant une endoscopie à champ de vision multidirectionnel |
WO2013177154A1 (fr) | 2012-05-21 | 2013-11-28 | The General Hospital Corporation | Appareil, dispositif et procédé pour microscopie par capsule |
EP2888616A4 (fr) | 2012-08-22 | 2016-04-27 | Gen Hospital Corp | Système, procédé et support accessible par ordinateur pour fabriquer des endoscopes miniatures à l'aide d'une lithographie douce |
US9445749B2 (en) * | 2013-01-21 | 2016-09-20 | Cornell University | Smartphone-based apparatus and method for obtaining repeatable, quantitative colorimetric measurement |
WO2014117130A1 (fr) | 2013-01-28 | 2014-07-31 | The General Hospital Corporation | Appareil et procédé devant fournir une spectroscopie diffuse co-enregistrée avec imagerie de domaine de fréquence optique |
WO2014120791A1 (fr) | 2013-01-29 | 2014-08-07 | The General Hospital Corporation | Appareil, systèmes et procédés pour donner des informations sur la valvule aortique |
US11179028B2 (en) | 2013-02-01 | 2021-11-23 | The General Hospital Corporation | Objective lens arrangement for confocal endomicroscopy |
US10478072B2 (en) | 2013-03-15 | 2019-11-19 | The General Hospital Corporation | Methods and system for characterizing an object |
US9784681B2 (en) | 2013-05-13 | 2017-10-10 | The General Hospital Corporation | System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence |
EP3021734B1 (fr) | 2013-07-19 | 2020-04-08 | The General Hospital Corporation | Appareil d'imagerie utilisant une endoscopie à champ de vision multidirectionnel |
EP3021735A4 (fr) | 2013-07-19 | 2017-04-19 | The General Hospital Corporation | Détermination de mouvement oculaire au moyen d'une imagerie de la rétine avec rétroaction d'un mouvement de l'oeil par imagerie de la rétine et fournir des informations en retour pour l'acquisition de signaux venant de la rétine |
WO2015013651A2 (fr) | 2013-07-26 | 2015-01-29 | The General Hospital Corporation | Système, appareil et procédé utilisant une dispersion optique pour réaliser une tomographie en cohérence optique dans le domaine de fourier |
JP6194791B2 (ja) * | 2013-12-27 | 2017-09-13 | 富士ゼロックス株式会社 | 画像処理装置及びプログラム |
US9733460B2 (en) | 2014-01-08 | 2017-08-15 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
US10736494B2 (en) | 2014-01-31 | 2020-08-11 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
WO2015153982A1 (fr) | 2014-04-04 | 2015-10-08 | The General Hospital Corporation | Appareil et procédé de commande de la propagation et/ou de la transmission d'un rayonnement électromagnétique dans un ou des guides d'ondes flexibles |
WO2016015052A1 (fr) | 2014-07-25 | 2016-01-28 | The General Hospital Corporation | Appareil, dispositifs et procédés d'imagerie in vivo et de diagnostic |
KR102492083B1 (ko) * | 2021-10-21 | 2023-01-27 | 주식회사 이뮤니스바이오 | 세포 카운트 방법 |
CN115541578B (zh) * | 2022-09-28 | 2023-10-24 | 佐健(上海)生物医疗科技有限公司 | 一种高通量超分辨宫颈细胞病理切片快速扫描分析*** |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0389003A1 (fr) * | 1985-10-04 | 1990-09-26 | Abbott Laboratories | Dispositif analytique en phase solide et procédé pour son utilisation |
EP0405091A1 (fr) * | 1989-04-27 | 1991-01-02 | Kyoto Daiichi Kagaku Co., Ltd. | Appareil d'analyse des composants des liquides de mesure |
WO1997020198A2 (fr) * | 1995-11-30 | 1997-06-05 | Chromavision Medical Systems, Inc. | Procede et appareil permettant d'effectuer l'analyse d'images automatisee d'echantillons biologiques |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5428690A (en) * | 1991-09-23 | 1995-06-27 | Becton Dickinson And Company | Method and apparatus for automated assay of biological specimens |
US5889881A (en) * | 1992-10-14 | 1999-03-30 | Oncometrics Imaging Corp. | Method and apparatus for automatically detecting malignancy-associated changes |
US5888742A (en) * | 1997-10-28 | 1999-03-30 | Incyte Pharmaceuticals, Inc. | Human phospholipid binding proteins |
-
2000
- 2000-07-12 JP JP2001510159A patent/JP2003504627A/ja active Pending
- 2000-07-12 WO PCT/US2000/019046 patent/WO2001004828A1/fr not_active Application Discontinuation
- 2000-07-12 AU AU60934/00A patent/AU6093400A/en not_active Abandoned
- 2000-07-12 EP EP00947299A patent/EP1203343A4/fr not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0389003A1 (fr) * | 1985-10-04 | 1990-09-26 | Abbott Laboratories | Dispositif analytique en phase solide et procédé pour son utilisation |
EP0405091A1 (fr) * | 1989-04-27 | 1991-01-02 | Kyoto Daiichi Kagaku Co., Ltd. | Appareil d'analyse des composants des liquides de mesure |
WO1997020198A2 (fr) * | 1995-11-30 | 1997-06-05 | Chromavision Medical Systems, Inc. | Procede et appareil permettant d'effectuer l'analyse d'images automatisee d'echantillons biologiques |
Non-Patent Citations (2)
Title |
---|
MARKS J R ET AL: "Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer." ANNALS OF SURGERY. APR 1994, vol. 219, no. 4, April 1994 (1994-04), pages 332-341, XP009069453 ISSN: 0003-4932 * |
See also references of WO0104828A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2003504627A (ja) | 2003-02-04 |
EP1203343A4 (fr) | 2006-08-23 |
WO2001004828A1 (fr) | 2001-01-18 |
AU6093400A (en) | 2001-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6546123B1 (en) | Automated detection of objects in a biological sample | |
WO2001004828A1 (fr) | Detection automatique d'objets dans un echantillon biologique | |
US7272252B2 (en) | Automated system for combining bright field and fluorescent microscopy | |
US7428325B2 (en) | Method and apparatus for automated image analysis of biological specimens | |
US7226788B2 (en) | Automated slide staining apparatus | |
US8712118B2 (en) | Automated measurement of concentration and/or amount in a biological sample | |
US20050037406A1 (en) | Methods and apparatus for analysis of a biological specimen | |
US6631203B2 (en) | Histological reconstruction and automated image analysis | |
EP1256087A1 (fr) | Procede et appareil destines a realiser une analyse d'image automatisee sur des echantillons biologiques | |
WO2001006446A1 (fr) | Procede automatise d'analyse d'image de proteine residuelle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020205 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060724 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G06K 9/00 20060101AFI20010123BHEP Ipc: G01N 1/31 20060101ALI20060719BHEP |
|
17Q | First examination report despatched |
Effective date: 20070209 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070810 |